Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacological treatment of compulsive sexual behaviour disorder
2024-514490-22-00Phase 3Withdrawn
- Sponsor
- Centrum Medyczne Kształcenia Podyplomowego
- Start
- Sep 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of naltrexone, escitalopram and paroxetine in hypersexuality, sponsored by Centrum Medyczne Kształcenia Podyplomowego. Primary endpoints: CSBD-19 score, BPS scale score and 2 more. Planned start Sep 2024; status: withdrawn.
02
Drugs
naltrexoneescitalopramparoxetine
03
Conditions
hypersexuality
Beyond the preview
Go deeper on 2024-514490-22-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-514490-22-00.